Abstract

Abundant data link hypercholesterolaemia to atherogenesis. However, only recently have we appreciated that inflammatory mechanisms couple dyslipidaemia to atheroma formation. Leukocyte recruitment and expression of pro-inflammatory cytokines characterize early atherogenesis, and malfunction of inflammatory mediators mutes atheroma formation in mice. Moreover, inflammatory pathways promote thrombosis, a late and dreaded complication of atherosclerosis responsible for myocardial infarctions and most strokes. The new appreciation of the role of inflammation in atherosclerosis provides a mechanistic framework for understanding the clinical benefits of lipid-lowering therapies. Identifying the triggers for inflammation and unravelling the details of inflammatory pathways may eventually furnish new therapeutic targets.

Keywords

AtheromaInflammationInflammatory responseMedicineMacrophageThrombosisDownregulation and upregulationImmunologyBioinformaticsBiologyCardiologyInternal medicine

MeSH Terms

AnimalsArteriosclerosisChemotaxisLeukocyteDisease SusceptibilityHumansInflammationLeukocytesRiskTunica Intima

Affiliated Institutions

Related Publications

Publication Info

Year
2002
Type
review
Volume
420
Issue
6917
Pages
868-874
Citations
8008
Access
Closed

Social Impact

Altmetric

Social media, news, blog, policy document mentions

Citation Metrics

8008
OpenAlex
13
Influential
6561
CrossRef

Cite This

Peter Libby (2002). Inflammation in atherosclerosis. Nature , 420 (6917) , 868-874. https://doi.org/10.1038/nature01323

Identifiers

DOI
10.1038/nature01323
PMID
12490960

Data Quality

Data completeness: 81%